# IN8BIO, Inc.: Form SCHEDULE 13D/A, filed Dec 29, 2025

- Company: [IN8BIO, Inc.](/companies/inab.md) (CIK 1740279)
- Form: SCHEDULE 13D/A
- Filed: 2025-12-29
- Accepted by EDGAR: Dec 29, 2025, 16:00 ET
- Period: not reported
- Accession: 0001714576-25-000003
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1740279/000171457625000003/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1740279/000171457625000003/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1740279/000171457625000003/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001714576-25-000003. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.